Sign in
Join
Discovery/Preclinical
In vitro
In vivo
Newer Targets
Clinical
Approval
FDA/EMA/Drug Designation
IND
Launch
NDA
Phase I
Phase II
Phase III
Phase IV
Recall
Commercial
Acquisitions
Conference/Award
Deals
Financial
Lawsuits/Bankruptcy
Lay off/Spin-off/Appointments
Merger
Patent
Pricing
Sign in
Welcome!
Log into your account
your username
your password
Forgot your password?
Sign up
Welcome!
Register for an account
your email
your username
A password will be e-mailed to you.
Password recovery
Recover your password
your email
Search
Sign in / Join
Contact
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Create an account
Create an account
Welcome! Register for an account
your email
your username
A password will be e-mailed to you.
Password recovery
Recover your password
your email
A password will be e-mailed to you.
Discovery/Preclinical
All
In vitro
In vivo
Newer Targets
Newer Targets
Gene therapy/gene editing combo could offer hope for some genetic disorders
Newer Targets
AmorChem Invests in Novel Approach to Target Myc-driven Cancers
Newer Targets
Researchers at Rush University Medical Center Find That Injecting Influenza Vaccines…
Newer Targets
Research Reveals Promising New Avenues for Anemia Treatment
Clinical
All
Approval
FDA/EMA/Drug Designation
IND
Launch
NDA
Phase I
Phase II
Phase III
Phase IV
Recall
Clinical
Hansa Biopharma Announces Long Term Follow-up Data That Demonstrates 2-year Graft…
Approval
Allergan’s Durysta Implant Approved to Treat Glaucoma
Phase III
AstraZeneca Bladder Cancer Treatment Fails to Hit the Mark in Phase…
Approval
Novadoz Pharmaceuticals Increases Presence in the Generic Oncology Market with an…
Commercial
All
Acquisitions
Conference/Award
Deals
Financial
Lawsuits/Bankruptcy
Lay off/Spin-off/Appointments
Merger
Patent
Pricing
Commercial
CEPI says funding gap of $2 billion could hamper COVID-19 vaccine…
Deals
AcelRx Announces Agreement for an Investigator-Initiated Study of DSUVIA in Patients…
Commercial
Seelos Therapeutics Receives Notice of Allowance for Composition of Matter Patent…
Deals
Announcement of Joint Research Agreement with Nagoya University for Spinal Cord…
Home
Commercial
Commercial
Latest
Latest
Featured posts
Most popular
7 days popular
By review score
Random
Commercial
CEPI says funding gap of $2 billion could hamper COVID-19 vaccine development
Firstwordpharma News
-
March 6, 2020
Deals
AcelRx Announces Agreement for an Investigator-Initiated Study of DSUVIA in Patients Undergoing Spine Surgery
Commercial
Seelos Therapeutics Receives Notice of Allowance for Composition of Matter Patent for SLS-007
Deals
Announcement of Joint Research Agreement with Nagoya University for Spinal Cord Injury
Deals
Announcement of Joint Research Agreement with Oita University for Peripheral Nerve Paralysis
Deals
Tetra Therapeutics and Shionogi Announce Expanded Alliance
Firstwordpharma News
-
March 6, 2020
0
Deals
Open Orphan: New hVIVO contract signed with a European Biotech Company
Firstwordpharma News
-
March 6, 2020
0
Acquisitions
ADVANZ PHARMA Corp. Limited Announces Definitive Agreement to Acquire The Rights...
Firstwordpharma News
-
March 6, 2020
0
Deals
Mount Sinai and Harbour BioMed Collaborate to Advance Novel Biotherapies for...
Biospace News
-
March 6, 2020
0
Commercial
Kadmon Highlights Recent Progress and Reports Fourth Quarter and Full Year...
Biospace News
-
March 5, 2020
0
1
2
3
...
476
Page 1 of 476
- Advertisement -
MOST POPULAR
China Has Big Presence in Top 10 Biotech IPOs this Year
July 17, 2019
Rapid relief of pain in oral mucositis, New episil oral liquid...
February 22, 2019
Moderna Sees Potential Blockbuster in Investigational Vaccine for Disease That Can...
January 10, 2020
Exercises Option to Exclusively License Base Editing Technology from Rutgers, The...
January 14, 2020
Load more
HOT NEWS
Deals
Merck and GSK Announce Global Alliance to Jointly Develop and Commercialize...
Phase I
Frequency Therapeutics Announces Positive Phase 1/2 Data for Drug Candidate for...
NDA
Gilead submits new drug application to U.S. Food and Drug Administration...
Commercial
MediciNova Receives Notice of Allowance for New Patent Covering MN-166 (ibudilast)...
